BLAST Search vs. Keyword Search in Biological Patents



In the world of intellectual property (IP), a thorough patent search is the bedrock of a solid legal strategy. For decades, text-based keyword searches have been the industry standard. If you want to find a patent for a "mechanical gear with a bevelled edge," you type in those exact terms, look for synonyms, and review the results.

But what happens when the invention you are trying to protect or investigate isn't made of steel, but of life itself?

In biotechnology, genomics, and therapeutics, inventions are frequently defined by amino acid or nucleotide sequences the precise chains of letters (A, C, T, G or single-letter protein codes) that dictate biological function. For these complex biological patents, relying solely on keyword searches isn't just inefficient; it’s a recipe for costly litigation.

Here is why traditional keyword searching falls short in the biotech arena and why biological sequence alignment tools like BLAST are non-negotiable.

1. Biological Nomenclature: Why Keyword Patent Searches Fail

Keyword searching relies on language, and language is notoriously flexible. In biology, a single gene or protein can have dozens of different names, acronyms, or historical aliases assigned by different research groups globally.

  • Synonym Overload: A researcher might patent a sequence referring to it as "HER2," while another patent calls it "ErbB2," "CD340," or "proto-oncogene Neu."
  • The Translation Trap: If you search only for the term "insulin," you completely miss patents that explicitly list the raw sequence of amino acids without using the specific term in the claims or title.

Sequence alignment tools bypass language entirely. Instead of searching for the labels humans give to biological entities, tools like BLAST (Basic Local Alignment Search Tool) search for the exact molecular blueprint.

2. Biological Variability: Percent Identity Matter

In mechanical or chemical patents, changing a single component often creates a brand-new invention. In biology, Nature allows for tweaks. A protein can have a few amino acids swapped out (mutations or polymorphisms) and still perform the exact same therapeutic function.

Patent drafters know this. To secure broad protection, biotech patents often claim a specific sequence and any sequence that has, for example, "85% or greater sequence identity" to it.

  • Why Keywords Fail: You cannot write a keyword query to capture "any sequence that looks 85% similar to this 500-character string of text."
  • How BLAST Wins: BLAST uses sophisticated algorithms to calculate biological similarity. It scores matches, penalizes gaps (insertions or deletions), and accounts for conservative substitutions where one amino acids is replaced by another with similar chemical properties. It flags sequences that are structurally and functionally similar, even if they aren't identical.

3. Dealing with Massive Scale and "Hidden" Sequences

Modern biological patents can contain thousands of sequences, sometimes hidden deep within massive accompanying data files complying with ST.25 or the standard ST.26 XML formats.

Attempting to screen these documents using traditional keyword-based PDF or OCR text readers is like looking for a specific needle in a field of haystacks. Human eyes simply cannot scan millions of character strings to detect a 15-base-pair match.

BLAST is purposefully built to handle these massive biological databases. It can index entire patent sequence repositories and cross-reference a query sequence in seconds, identifying localized regions of high similarity that a text search engine would completely overlook.

4. Homology and Fragment Searching

Sometimes, the threat to your patent portfolio doesn't come from an identical gene, but from a fragment of it, or an evolutionary relative (homolog) found in a different organism.

  • The Fragment Problem: If a competitor patents a short primer, probe, or a specific CDR (complementarity-determining region) of an antibody, a keyword search won't tell you if that short fragment matches a portion of your larger therapeutic protein.
  • The BLAST Advantage: BLAST allows for "local alignment," meaning it can find short, highly conserved regions of similarity within much larger, otherwise unrelated sequences.

The Verdict: A Dual-Engine Approach is Key

Does this mean keyword searching is dead in biotech? Absolutely not.

A truly robust biological patent search requires a hybrid approach. Keywords remain essential for capturing the context of the invention such as specific disease indications, formulations, delivery mechanisms, or methods of use.

However, the keyword search is merely the frame; the sequence alignment tool is the lens. Without BLAST or specialized sequence search engines, any biotech freedom-to-operate (FTO) or patentability assessment is fundamentally incomplete. In the high-stakes race of synthetic biology and personalized medicine, biological alignment tools aren't just a luxury they are an absolute legal necessity.

Secure Your Biotech Innovations with Expert Precision

As an expert partner in IP asset management, Einfolge provides comprehensive Chemical Structure and Sequence Search Services utilizing advanced BLAST and alignment tools to safeguard your biological discoveries. Contact Us today to secure your Freedom to Operate.